Compare · ESP vs TMO
ESP vs TMO
Side-by-side comparison of Espey Mfg. & Electronics Corp. (ESP) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- ESP operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $225.41B, about 7115.0x ESP ($31.7M).
- TMO has hit the wire 6 times in the past 4 weeks while ESP has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 0 for ESP).
- Company
- Espey Mfg. & Electronics Corp.
- Thermo Fisher Scientific Inc
- Price
- $71.21-0.77%
- $469.57+0.63%
- Market cap
- $31.7M
- $225.41B
- 1M return
- +31.89%
- -
- 1Y return
- +132.33%
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- AMEX
- NYSE
- IPO
- 1960
- News (4w)
- 0
- 6
- Recent ratings
- 0
- 25
Espey Mfg. & Electronics Corp.
Espey Mfg. & Electronics Corp., a power electronics design and original equipment manufacturing company, designs, manufactures, and tests electronic equipment primarily for use in military and industrial applications in the United States and internationally. Its principal products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, antennas, and high power radar systems for use in AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power applications. The company also provides various services that consist of design and development to specification, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment. It serves industrial manufacturers and defense companies, the government of the United States, foreign governments, and foreign electronic equipment companies through its direct sales organization and outside sales representatives. Espey Mfg. & Electronics Corp. was founded in 1928 and is based in Saratoga Springs, New York.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest ESP
- Espey Announces Regular Quarterly Dividend of $0.25 Per Share
- Director Helmetag Carl exercised 1,600 units of Common Stock - $.33 1/3 par value at a strike of $26.25, increasing direct ownership by 8% to 22,169 units (SEC Form 4)
- Director Wool Michael W sold $57,900 worth of Common Stock - $.33 1/3 par value (1,000 units at $57.90) and exercised 1,842 units of Common Stock - $.33 1/3 par value at a strike of $27.21, increasing direct ownership by 5% to 19,242 units (SEC Form 4)
- Director Corr Paul J sold $138,963 worth of Common Stock - $.33 1/3 par value (2,400 units at $57.90), decreasing direct ownership by 11% to 20,439 units (SEC Form 4)
- Director Corr Paul J exercised 4,642 units of Common Stock - $.33 1/3 par value at a strike of $24.39 and sold $130,562 worth of Common Stock - $.33 1/3 par value (2,242 units at $58.23), increasing direct ownership by 12% to 22,839 units (SEC Form 4)
- President & CEO Oneil David A exercised 7,675 units of Common Stock - $.33 1/3 par value at a strike of $24.85 and sold $442,800 worth of Common Stock - $.33 1/3 par value (8,856 units at $50.00), decreasing direct ownership by 7% to 16,250 units (SEC Form 4)
- Espey Mfg. & Electronics Corp. reports second quarter results
- SEC Form 10-Q filed by Espey Mfg. & Electronics Corp.
- Director Wool Michael W exercised 2,000 units of Common Stock - $.33 1/3 par value at a strike of $21.75, increasing direct ownership by 12% to 18,400 units (SEC Form 4)
- President & CEO Oneil David A sold $92,540 worth of Common Stock - $.33 1/3 par value (2,000 units at $46.27), decreasing direct ownership by 10% to 17,431 units (SEC Form 4)
Latest TMO
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports First Quarter 2026 Results
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
- Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics
- SEC Form DEFA14A filed by Thermo Fisher Scientific Inc
- SEC Form DEF 14A filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026
- SEC Form 4 filed by Sperling Scott M
- SEC Form 4 filed by Keith R. Alexandra
- SEC Form 4 filed by Lynch Karen S